Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05278195
What this trial is testing

Assessing the Prognosis of TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for HCC by Using Clinical and Imaging Biomarkers

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 300
Large-scale testing (Phase 3)UnknownNCT04722952
What this trial is testing

PD-1 Inhibitor Combined With Azacytidine and Homoharringtonine，Cytarabine, G-CSF for Refractory or Relapsed AML

Who this might be right for
ImmunotherapyRefractory LeukemiaRelapsed Adult AML+1 more
The First Affiliated Hospital of Soochow University 30
Large-scale testing (Phase 3)UnknownNCT04490421
What this trial is testing

Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer.

Who this might be right for
Lung NeoplasmSmall Cell Lung CancerPD-1 Inhibitors
Fuzhou General Hospital 45
Large-scale testing (Phase 3)Looking for participantsNCT03952065
What this trial is testing

IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Who this might be right for
Head/Neck Neoplasm
Second Affiliated Hospital of Guangzhou Medical University 200
Testing effectiveness (Phase 2)Study completedNCT03761914
What this trial is testing

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

Who this might be right for
Acute Myelogenous LeukemiaOvarian CancerColorectal Cancer+2 more
Sellas Life Sciences Group 26
Testing effectiveness (Phase 2)UnknownNCT04267549
What this trial is testing

Conversion Therapy of Sintilimab in Combination With Apatinib and Chemotherapy in Stage IV Gastric Cancer

Who this might be right for
Gastric Cancer Stage IV
Tianjin Medical University Cancer Institute and Hospital 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535632
What this trial is testing

SBRT Followed by PD-1 Inhibitor, Bevacizumab and TAS-102 as Third-Line Therapy for Recurrent/Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Shanghai Zhongshan Hospital 58
Testing effectiveness (Phase 2)Looking for participantsNCT05700721
What this trial is testing

Phase II Trial of the PARP Inhibitor Niraparib and PD-1 Inhibitor Dostarlimab in Patients With Advanced Cancers With Active Progressing Brain Metastases (STARLET)

Who this might be right for
Brain Metastases
M.D. Anderson Cancer Center 120
Not applicableNot Yet RecruitingNCT06945601
What this trial is testing

The Effect of Previous Pregnancies in Patients With Gynecological Neoplasms Treated With PD-1/PD-L1 Inhibitors

Who this might be right for
Gynecologic Cancers
IRCCS San Raffaele 150
Testing effectiveness (Phase 2)UnknownNCT04767009
What this trial is testing

SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
NSCLC Stage IV
Fudan University 59
Testing effectiveness (Phase 2)UnknownNCT04486287
What this trial is testing

Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
OligometastasisLung Neoplasms
Tianjin Medical University Second Hospital 44
Early research (Phase 1)Study completedNCT02403193
What this trial is testing

Trial of PBF-509 and PDR001 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Palobiofarma SL 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06835179
What this trial is testing

SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.

Who this might be right for
Unresectable Metastatic Colorectal CancerMicrosatellite Stable (MSS) Colorectal Cancer (CRC)RAS-mutant Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University 28
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07555860
What this trial is testing

Becotatug Vedotin Plus PD-1 Monoclonal Antibody and Radiotherapy for Unresectable Locally Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 28
Testing effectiveness (Phase 2)Study completedNCT04988841
What this trial is testing

Assessing the Tolerance and Clinical Benefit of feCAl tranSplantation in patientS With melanOma

Who this might be right for
Melanoma
Assistance Publique - Hôpitaux de Paris 70
Testing effectiveness (Phase 2)Looking for participantsNCT03591276
What this trial is testing

Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Shaare Zedek Medical Center 15
Not applicableUnknownNCT05435768
What this trial is testing

PraG With RANKL Inhibitor for the Treatment of Advanced Multiple Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumor
Second Affiliated Hospital of Soochow University 51
Not applicableLooking for participantsNCT07249060
What this trial is testing

Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Who this might be right for
Immune-Related Adverse EventsLupus Erythematosus, SystemicSjogren Syndrome+3 more
Hospital Universitario Araba 300
Testing effectiveness (Phase 2)Looking for participantsNCT07209059
What this trial is testing

PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaHodgkin DiseaseAdvanced Hodgkin Lymphoma
National Research Center for Hematology, Russia 30
Testing effectiveness (Phase 2)Looking for participantsNCT05961761
What this trial is testing

Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients

Who this might be right for
Soft Tissue Sarcoma AdultAngiosarcomaUndifferentiated Pleomorphic Sarcoma
Niels Junker 80
Next Page